Tout DSpace

Afficher la notice abrégée

HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT

dc.creatorGoulis, L.en
dc.creatorAkriviadis, E.en
dc.creatorKaratapanis, S.en
dc.creatorDeutsch, M.en
dc.creatorDalekos, G. N.en
dc.creatorRaptopoulou-Gigi, M. P.en
dc.creatorDrakoulis, C.en
dc.creatorMimidis, K.en
dc.creatorGermanidis, G.en
dc.creatorNikolopoulou, V.en
dc.creatorChounta, A.en
dc.creatorBakalos, G.en
dc.creatorPapatheodoridis, G. V.en
dc.date.accessioned2015-11-23T10:28:51Z
dc.date.available2015-11-23T10:28:51Z
dc.date.issued2011
dc.identifier.issn0270-9139
dc.identifier.urihttp://hdl.handle.net/11615/28109
dc.source.uri<Go to ISI>://WOS:000295578003614
dc.subjectGastroenterology & Hepatologyen
dc.titleHBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORTen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée